Home | Business News | Browse by Publication | M | M2 Presswire

Orphaned in Europe.

Publication: M2 Presswire
Publication Date: 31-OCT-06
Format: Online
Delivery: Immediate Online Access

Article Excerpt
M2 PRESSWIRE-31 October 2006-bellwetherreport.com: Orphaned in Europe(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:31102006

CytRx (NASDAQ:CYTR) has partnering with the medical school of the University of Massachusetts CytRx is into developing treatments for obesity, type 2 diabetes, neurodegenerative disease, and cytomegalovirus using RNA interface (RNAi) technology. Its lead drug candidate in this area, arimoclomal, could treat amyotrophic lateral sclerosis, Lou Gehrig's disease. The drug has received orphan and fast track status from the FDA. The company is also developing small molecule therapies with applications in diabetes, neurology, and cardiology. The candidate has...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from M2 Presswire
Mining for Water., October 31, 2006
Hot Stock List!, October 31, 2006
Hot Stock Highlights!, October 31, 2006
Sales High Though Volume Remained Flat., October 31, 2006
Technology That Can Raise Guidance?, October 31, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.